CA2354253A1 - Polypetides ou adices nucleiques codant les polypeptides de recepteurs couples de la famille des proteines g, et leur utilisation pour le diagnostic ou le traitement de troubles, notamment de troubles cutanes, et leur utilisation pour l'identification de substances pharmacologiquement actives - Google Patents

Polypetides ou adices nucleiques codant les polypeptides de recepteurs couples de la famille des proteines g, et leur utilisation pour le diagnostic ou le traitement de troubles, notamment de troubles cutanes, et leur utilisation pour l'identification de substances pharmacologiquement actives Download PDF

Info

Publication number
CA2354253A1
CA2354253A1 CA002354253A CA2354253A CA2354253A1 CA 2354253 A1 CA2354253 A1 CA 2354253A1 CA 002354253 A CA002354253 A CA 002354253A CA 2354253 A CA2354253 A CA 2354253A CA 2354253 A1 CA2354253 A1 CA 2354253A1
Authority
CA
Canada
Prior art keywords
polypeptide
nucleic acid
wound healing
acid encoding
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002354253A
Other languages
English (en)
Inventor
Eckhard Wolf
Sabine Werner
Jorn-Peter Halle
Johannes Regenbogen
Andreas Goppelt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Switch Biotech AG
Original Assignee
Switch Biotech Ag
Eckhard Wolf
Sabine Werner
Jorn-Peter Halle
Johannes Regenbogen
Andreas Goppelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2000138111 external-priority patent/DE10038111A1/de
Application filed by Switch Biotech Ag, Eckhard Wolf, Sabine Werner, Jorn-Peter Halle, Johannes Regenbogen, Andreas Goppelt filed Critical Switch Biotech Ag
Publication of CA2354253A1 publication Critical patent/CA2354253A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
CA002354253A 2000-08-04 2001-07-31 Polypetides ou adices nucleiques codant les polypeptides de recepteurs couples de la famille des proteines g, et leur utilisation pour le diagnostic ou le traitement de troubles, notamment de troubles cutanes, et leur utilisation pour l'identification de substances pharmacologiquement actives Abandoned CA2354253A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2000138111 DE10038111A1 (de) 2000-08-04 2000-08-04 Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren einer Familie von G-Protein gekoppelten Rezeptoren zur Diagnose oder Behandlung von Erkrankungen, beispielsweise Hautkrankheiten, sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen
DE10038111.1 2000-08-04
US22950100P 2000-08-31 2000-08-31
US60/229,501 2000-08-31

Publications (1)

Publication Number Publication Date
CA2354253A1 true CA2354253A1 (fr) 2002-02-04

Family

ID=26006614

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002354253A Abandoned CA2354253A1 (fr) 2000-08-04 2001-07-31 Polypetides ou adices nucleiques codant les polypeptides de recepteurs couples de la famille des proteines g, et leur utilisation pour le diagnostic ou le traitement de troubles, notamment de troubles cutanes, et leur utilisation pour l'identification de substances pharmacologiquement actives

Country Status (6)

Country Link
US (1) US20020116724A1 (fr)
EP (1) EP1178053A3 (fr)
JP (1) JP2003000267A (fr)
AU (1) AU5780801A (fr)
CA (1) CA2354253A1 (fr)
IL (1) IL144655A0 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040143092A1 (en) * 2001-02-08 2004-07-22 Alex Smolyar Regulation of human dorsal root receptor-like g protein-coupled receptor
WO2003046147A2 (fr) * 2001-11-26 2003-06-05 Bristol-Myers Squibb Company Nouveau recepteur couple a la proteine g humaine, hgprbmy31, variants et procedes d'utilisation de ce dernier
US20030171293A1 (en) * 2002-02-27 2003-09-11 Pfizer Inc. Neuropeptide receptor and uses thereof
WO2004000999A2 (fr) * 2002-06-21 2003-12-31 California Institute Of Technology Identification d'une migration regulee de recepteurs et metastase des cellules cancereuses de la peau
US7056685B1 (en) 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9704836D0 (sv) * 1997-12-22 1997-12-22 Astra Pharma Inc Novel receptor
JP2000023676A (ja) * 1998-07-14 2000-01-25 Asahi Chem Ind Co Ltd 7回膜貫通型受容体蛋白質erg5
JP2000023677A (ja) * 1998-07-14 2000-01-25 Asahi Chem Ind Co Ltd 7回膜貫通型受容体蛋白質erg9
IL149569A0 (en) * 1999-11-17 2002-11-10 Arena Pharm Inc Endogenous and non-endogenous versions of human g protein-coupled receptors
EP1242454A2 (fr) * 1999-12-28 2002-09-25 PHARMACIA & UPJOHN COMPANY Nouveaux recepteurs couples a une proteine g
CA2399982A1 (fr) * 2000-02-02 2001-08-09 Incyte Genomics, Inc. Recepteurs couples aux proteines g

Also Published As

Publication number Publication date
JP2003000267A (ja) 2003-01-07
AU5780801A (en) 2002-02-07
EP1178053A2 (fr) 2002-02-06
US20020116724A1 (en) 2002-08-22
IL144655A0 (en) 2002-05-23
EP1178053A3 (fr) 2002-03-20

Similar Documents

Publication Publication Date Title
US6043083A (en) Inhibitors of the JNK signal transduction pathway and methods of use
US6586185B2 (en) Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances
JP2001292783A (ja) 皮膚疾患の診断または治療のためのポリペプチドまたはこれらをコードする核酸の使用、および薬理学上活性な物質を同定するためのそれらの使用
WO2004029287A2 (fr) Polypeptides et acides nucleiques codant ceux-ci et utilisation de ceux-ci pour la prevention, le diagnostic ou le traitement de troubles du foie et du cancer epithelial
CA2354253A1 (fr) Polypetides ou adices nucleiques codant les polypeptides de recepteurs couples de la famille des proteines g, et leur utilisation pour le diagnostic ou le traitement de troubles, notamment de troubles cutanes, et leur utilisation pour l'identification de substances pharmacologiquement actives
WO2002090552A2 (fr) Utilisation de polypeptides, ou d'acides nucleiques les codant, d'une 2'-5'-oligoadenylate synthetase et/ou d'arnsel pour le diagnostic, la prevention ou le traitement de cicatrisation de plaies, et leur utilisation afin d'identifier des substances actives sur le plan pharmacologique
US20060052320A1 (en) Mammalian genes involved in rapamycin resistance and tumorgenesis annexin XIII genes
US20020034741A1 (en) Use of polypeptides or nucleic acids encoding these of the gene family NM23 for the diagnosis or treatment of skin or intestinal disorders, and their use for the identification of pharmacologically active substances
US20060099676A1 (en) Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes
AU784052B2 (en) Novel human proteins and polynucleotides encoding the same
US20030180302A1 (en) Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances
US20060240021A1 (en) Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes
US20020081601A1 (en) Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
US6682920B1 (en) Compositions and methods for identifying PKB kinase inhibitors
WO1999016887A2 (fr) Compositions et techniques permettant d'identifier les inhibiteurs de la kinase de la pkb
EP1434598A2 (fr) Proteines de bestrophine et homologues de bestrophine impliquees dans la regulation de l'homeostasie de l'energie
NZ577564A (en) Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
US20020038013A1 (en) Novel human membrane proteins and polynucleotides encoding the same
US20050053953A1 (en) Novel human genes and proteins encoded thereby
JP2001322947A (ja) 遺伝子ファミリーnm23のポリペプチドまたはこれらをコードする核酸の、皮膚または腸障害の診断または治療のための使用、およびそれらの、薬理学的に活性がある物質の同定のための使用
AU7168400A (en) Use of polypeptides or nucleic acids encoding these for the diagnosis or treatment of skin disorders, and their use for the identification of pharmacologically active substances
EP1499340A2 (fr) Proteines impliquees dans la regulation de l'homeostasie energetique
WO2003066087A2 (fr) Kinases impliquees dans la regulation de l'homeostasie energetique
WO2000075320A2 (fr) Genes humains et proteines codees par ces genes
WO2003037929A1 (fr) Polynucleotides codant des polypeptides du canal potassique humain

Legal Events

Date Code Title Description
FZDE Discontinued